Aris Tagalakis

Dr Tagalakis joined Edge Hill University in February 2018 as a Senior Lecturer (Associate Professor) in Human Biology and promoted to Reader in 2020. He studied Biochemistry and Biotechnology at Royal Holloway University of London. He then had the privilege during his PhD at UCL Royal Free Medical School (funded by a prestigious British Heart Foundation studentship where he worked on gene therapy for atherosclerosis) to be supervised by Professor Jim Owen and Professor George Dickson. He then spent over 14 years at UCL, initially as a Research Fellow (Sir Henry Wellcome fellowship), and later as a Senior Research Fellow at UCL Royal Free Medical School and at UCL Great Ormond Street Institute of Child Health. His research interests include the development of gene and RNA delivery/therapy strategies and gene editing using nanoparticles for a range of diseases including cancer, respiratory, ocular, cardiovascular, brain disorders and rare diseases. He is a reviewer of grants from different funding bodies, a regular reviewer of many leading scientific journals, serves in editorial boards and is a consultant advising pharmaceutical and small biotech companies. He currently serves as a Scientific Committee member of the American Society of Gene and Cell Therapy. He is also an Associate Professor at UCL.